Form 4 for RXO RXO, Inc.
Accepted 2025-11-17 00:00:00 ET · period of report 2025-11-14 · accession 0000950142-25-003007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-17 | 2025-11-14 | RXO | Wilkerson Andrew M. | CEO, Dir | M - OptEx | $0.00 | +1,565 | 5,415 | +41% | $0 |
| D | 2025-11-17 | 2025-11-14 | RXO | Wilkerson Andrew M. | CEO, Dir | F - Tax | $10.86 | -684 | 4,731 | -13% | -$7,428 |
| D | 2025-11-17 | 2025-11-14 | RXO | Wilkerson Andrew M. | CEO, Dir | M - OptEx | $0.00 | -1,565 | 606.0K | -0.3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-14 | M | A | 1,565 | $0.00 | 5,415 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-14 | F | D | 684 | $10.86 | 4,731 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2025-11-14 | M | D | 1,565 | $0.00 | 605,967 | D | — · — to — | 1,565 Common Stock | (F5) Includes 74,932 RSUs previously reported separately in Table II in the Reporting Person's Form 4 filed on March 4, 2025. (F3) Each RSU represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. (F4) The RSUs vested at 50% on the second anniversary of the grant date and the remaining award vested in two equal installments on the third and fourth anniversaries of the grant date. |